Towa Pharmaceutical Co., Ltd. (4553.T) JPX

Currency In JPY

AD

Valuation

Market Cap197.16B
Enterprise Value378.59B
P/E Ratio23.19
PEG Ratio-0.48
Price/Sales Ratio0.68
Price/Book Ratio1.05
Enterprise/Revenue1.36
Enterprise/EBITDA9.46

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.03
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.05

Income Statement

Revenue273.71B
Revenue/Share5,686.62
Gross Profit99.1B
EBITDA38.26B
Net Income5.25B
Diluted EPS106.65

Balance Sheet

Total Cash42.23B
Total Cash/Share857.82
Total Debt229.93B
Total Debt/Equity1.26
Current Ratio2.82
Book Value Per Share3,706.81

Price History

52-Week Change28.13
52-Week High4,490
52-Week Low2,764
Moving Average 50 Days3,934.8
Moving Average 200 Days3,810.09

Statistics

Average Volume130,122
Shares Outstanding49.23M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate80
Trailing Annual Dividend Yield2.05
Payout Ratio0.48
Last Split Factor3:1
Last Split DateMarch 27, 2019
AD